SCHEMBL4293154

SCHEMBL4293154

C=CCc1cc(N)n(C(C)=O)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKE Q14164 2/20 0.37
IKBKB O14920 2/20 0.37
CHEK1 O14757 1/20 0.36
AURKA O14965 1/20 0.36
DAPK3 O43293 1/20 0.36
CSNK1A1 P48729 1/20 0.36
GSK3A P49840 1/20 0.36
LIMK1 P53667 1/20 0.36
MAPK14 Q16539 1/20 0.36
TAOK1 Q7L7X3 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
MAP3K14 Q99558 3/20 0.35
CASP1 P29466 1/20 0.34
PDGFRA P16234 1/20 0.34
CDK5 Q00535 1/20 0.34
TYRO3 Q06418 1/20 0.34
ALDH1A1 P00352 1/20 0.33
TSHR P16473 2/20 0.32
HSD17B10 Q99714 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2488796 0.85 KDM4E (0.31) TSHRHSD17B10KDM4EGAASMN1; SMN2
SCHEMBL11009719 0.74 ADORA2A (0.31) NPSR1
SCHEMBL674107 0.73 SMN1; SMN2 (0.32) SMN1; SMN2NPSR1
SCHEMBL11421005 0.67
SCHEMBL9492907 0.67 TLR8 (0.35)
Hydrochloric Acid SCHEMBL10712022 0.64 GRN (0.40) ALDH1A1TSHRHSD17B10KDM4EGAA
SCHEMBL10712020 0.64 ALDH1A1 (0.32) ALDH1A1TSHRSMN1; SMN2
SCHEMBL10582024 0.63 IMPDH2 (0.33) NPSR1
Acetic Acid SCHEMBL10491859 0.61 HSD17B10 (0.56) ALDH1A1HSD17B10KDM4ESMN1; SMN2KMT2A
SCHEMBL22454131 0.61 BCHE (0.46) ALDH1A1TSHRHSD17B10KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090192192-A1 INHIBITORS OF BIOFILM FORMATION OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA TOUCH BIONICS LIMITED (GB) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192192-A1 INHIBITORS OF BIOFILM FORMATION OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA PGLS, TFPI, Q6ZSR9 IKBKE 308/4885IKBKB 212/4885CHEK1 3904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.